When it comes to investing in pharmaceutical companies, looking at pipelines and research and development prospects is ...

Other companies are developing oral antivirals for COVID-19, notably Merck & Co and Ridgeback Biotherapeutics' molnupiravir and Pfizer's PF-07321332, which have both just moved into phase 3 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

After hours: 7:59:57 p.m. EST Loading Chart for MRK ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...